Epitor

Epitor Therapeutics is a leading epigenetic editing company dedicated to treating diseases by altering pathological gene expression without directly editing or disrupting the genome. This innovative approach therapeutically activates necessary genes or suppresses the expression of toxic genes. Using ultra-compact tools, Epitor delivers drugs to various tissues to treat diseases through precise control of gene expression. The company's internal projects focus on X reactivation and nucleotide repeat disorders.